Hong Kong · Delayed Price · Currency is HKD BeOne Medicines AG Statistics
Total Valuation
HKG:6160 has a market cap or net worth of HKD 379.35 billion. The enterprise value is 342.37 billion.
| Market Cap | 379.35B |
| Enterprise Value | 342.37B |
Important Dates
The last earnings date was Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 1.37B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +4.74% |
| Shares Change (QoQ) | +5.49% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.06B |
Valuation Ratios
The trailing PE ratio is 48.00 and the forward PE ratio is 43.06.
| PE Ratio | 48.00 |
| Forward PE | 43.06 |
| PS Ratio | 7.51 |
| PB Ratio | 8.23 |
| P/TBV Ratio | 8.45 |
| P/FCF Ratio | 32.64 |
| P/OCF Ratio | 29.93 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 30.22, with an EV/FCF ratio of 29.46.
| EV / Earnings | 42.86 |
| EV / Sales | 6.78 |
| EV / EBITDA | 30.22 |
| EV / EBIT | 35.03 |
| EV / FCF | 29.46 |
Financial Position
The company has a current ratio of 3.64, with a Debt / Equity ratio of 0.20.
| Current Ratio | 3.64 |
| Quick Ratio | 3.18 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | 0.79 |
| Debt / FCF | 0.78 |
| Interest Coverage | 21.69 |
Financial Efficiency
Return on equity (ROE) is 19.86% and return on invested capital (ROIC) is 63.15%.
| Return on Equity (ROE) | 19.86% |
| Return on Assets (ROA) | 8.75% |
| Return on Invested Capital (ROIC) | 63.15% |
| Return on Capital Employed (ROCE) | 16.32% |
| Weighted Average Cost of Capital (WACC) | 7.64% |
| Revenue Per Employee | 4.22M |
| Profits Per Employee | 666,915 |
| Employee Count | 12,000 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 0.96 |
Taxes
In the past 12 months, HKG:6160 has paid 1.70 billion in taxes.
| Income Tax | 1.70B |
| Effective Tax Rate | 17.55% |
Stock Price Statistics
The stock price has increased by +28.86% in the last 52 weeks. The beta is 0.63, so HKG:6160's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +28.86% |
| 50-Day Moving Average | 220.26 |
| 200-Day Moving Average | 196.76 |
| Relative Strength Index (RSI) | 66.34 |
| Average Volume (20 Days) | 3,898,203 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:6160 had revenue of HKD 50.58 billion and earned 8.00 billion in profits. Earnings per share was 5.25.
| Revenue | 50.58B |
| Gross Profit | 45.43B |
| Operating Income | 9.91B |
| Pretax Income | 9.71B |
| Net Income | 8.00B |
| EBITDA | 11.04B |
| EBIT | 9.91B |
| Earnings Per Share (EPS) | 5.25 |
Balance Sheet
The company has 46.05 billion in cash and 9.06 billion in debt, with a net cash position of 36.99 billion.
| Cash & Cash Equivalents | 46.05B |
| Total Debt | 9.06B |
| Net Cash | 36.99B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 46.19B |
| Book Value Per Share | 31.14 |
| Working Capital | 45.46B |
Cash Flow
In the last 12 months, operating cash flow was 12.70 billion and capital expenditures -1.06 billion, giving a free cash flow of 11.64 billion.
| Operating Cash Flow | 12.70B |
| Capital Expenditures | -1.06B |
| Depreciation & Amortization | 1.13B |
| Net Borrowing | 884.77M |
| Free Cash Flow | 11.64B |
| FCF Per Share | n/a |
Margins
Gross margin is 89.81%, with operating and profit margins of 19.59% and 15.82%.
| Gross Margin | 89.81% |
| Operating Margin | 19.59% |
| Pretax Margin | 19.19% |
| Profit Margin | 15.82% |
| EBITDA Margin | 21.83% |
| EBIT Margin | 19.59% |
| FCF Margin | 23.02% |
Dividends & Yields
HKG:6160 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.22% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.74% |
| Shareholder Yield | -4.74% |
| Earnings Yield | 2.08% |
| FCF Yield | 3.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for HKG:6160 is 278.67, which is 10.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 278.67 |
| Price Target Difference | 10.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 18.67% |
| EPS Growth Forecast (3Y) | 90.55% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |